AI assistant
CONTROL BIONICS LIMITED — Board/Management Information 2022
Sep 14, 2022
64611_rns_2022-09-14_468debeb-cc22-4dbb-a50e-55e059c0d796.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [177 x 63] intentionally omitted <==
15 September 2022
ASX ANNOUNCEMENT
CEO Resignation
It is with deep regret that we announce the resignation of our CEO, Rob Wong, due to an ongoing, degenerative medical condition.
Rob has been on sick leave for the last 2 months seeking treatment and taking time to recover, during which time our Company Founder, Peter Ford, has stepped into the CEO role on a temporary basis.
Rob has now concluded that he will be unable to perform the demanding role of CEO, and instead must focus his energy on his health and his family. The Board has commenced a search process for a new permanent CEO.
Rob Wong remains a significant shareholder and is making himself available in an advisory capacity as needed, and will assist with the transition to a new CEO at the appropriate time.
We wish Rob all the very best with his ongoing treatment and recovery.
This announcement was authorised by CBL Chairman, Roger Hawke.
Control Bionics Limited Registered Office: Level 5, Suite 5.01, 697 Burke Road, Camberwell, Vic., 3124 T: +61 3 9897 3576 W: www.controlbionics.com
ABN: 45 115 465 462